SOURCE: Xtalks

Xtalks Webinars

September 21, 2015 15:00 ET

Top News Stories You Might have Missed From Xtalks

TORONTO, ON--(Marketwired - September 21, 2015) - Xtalks provides current articles daily in the life science industry. Check out all our news stories here: http://xtalks.com/News.ashx.

Improving Drug Solubility By Preventing Crystallization -- http://ow.ly/StMwh
(Sep 21) Researchers have developed a new method to prevent the crystallization of active compounds, thereby increasing bioavailability.

Combination of Three Antibiotics Effective Against MRSA Bacteria -- http://ow.ly/StMAJ
(Sep 21) Researchers have found that a combination of three antibiotics is an effective treatment against Methicillin-resistant Staphylococcus aureus (MRSA) infection.

New Ultrasound Device Developed to Clean Medical Instruments -- http://ow.ly/StMGp
(Sep 18) A tool that uses water and ultrasonic waves to disinfect medical devices, has been developed by researchers at the University of Southampton.

Merck's Once-A-Week Diabetes Drug As Effective As Januvia -- http://ow.ly/StNZa
(Sep 18) Merck & Co. is preparing to submit an application to the FDA for its once-weekly diabetes pill, omarigliptin.

Dr. Robert Califf Nominated for FDA Commissioner by President Obama -- http://ow.ly/StMNC
(Sep 17) President Barack Obama announced Tuesday that he would be recommending Dr. Robert Califf -- a prominent cardiologist and researcher -- as the next commissioner of the US Food and Drug Administration (FDA).

Amgen Acquires Dezima for $1.55 Billion in an Effort to Boost Its Cardio Drug Portfolio -- http://ow.ly/StMRy
(Sep 17) Netherlands-based biotech Dezima, have accepted a $1.55 billion deal from Amgen which includes the acquisition of the company's midstage low-density lipoprotein cholesterol LDL-C treatment.

Hepatocellular Carcinoma Screening in Cirrhosis Patients Boosted By Outreach Efforts -- http://ow.ly/StMY5
(Sep 16) According to results presented at the 9th Annual International Liver Cancer Association Conference in Paris, France, patients with cirrhosis of the liver were much more likely to participate in one-time hepatocellular carcinoma (HCC) screening, if they received a reminder letter in the mail.

Identifying Ideal Candidates for Fetal Spina Bifida Surgery -- http://ow.ly/StN3z
(Sep 16) The National Institutes of Health (NIH) have supported a study which suggests that fetuses with swollen ventricles may be less likely to benefit from in utero surgery to treat spina bifida.

Understanding the Major Complication of Parkinson's Treatment -- http://ow.ly/StN8v
(Sep 15) While L-DOPA (levodopa) is the most effect treatment available for Parkinson's disease, it commonly leads to dyskinesia -- a poorly-understood side-effect characterized by uncontrolled muscle movement -- which can be just a difficult to deal with as the disease itself.

Bacterial Link Between Gum Disease and Heart Disease -- http://ow.ly/StNdx
(Sep 15) While gum disease and heart disease have long been known to be associated by a bacterial infection common to both illnesses, a new study out of Orebro University in Sweden has clarified the link.

ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.

Contact Information